Literature DB >> 23621247

MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis.

Qiang Huang1, Lei Liu, Chen-Hai Liu, Hao You, Feng Shao, Fang Xie, Xian-Sheng Lin, San-Yuan Hu, Chuan-Hai Zhang.   

Abstract

BACKGROUND: MicroRNAs are noncoding RNA molecules that posttranscriptionally regulate gene expression. The aim of this study was to determine the role of microRNA-21 in cholangiocarcinomas and its relationship to cholangiocarcinoma RBE cell capacity for invasion and metastasis.
METHODS: MicroRNA-21 expression was investigated in 41 cases of cholangiocarcinoma samples by in situ hybridization and real-time PCR. Influence on cholangiocarcinoma cell line invasion and metastasis was analyzed with microRNA-21 transfected cells. In addition, regulation of reversion-inducing-cysteine-rich protein with kazal motifs (RECK) by microRNA-21 was elucidated to identify mechanisms.
RESULTS: In situ hybridization and real-time quantitative PCR results for patients with lymph node metastasis or perineural invasion showed significantly high expression of microRNA-21 (P<0.05). There was a dramatic decrease in cholangiocarcinoma cell line invasion and metastasis ability after microRNA-21 knockdown (P<0.05). However, overexpression significantly increased invasion and metastasis (P<0.05). Real-time PCR and Western-blot analysis showed that microRNA-21 could potentially inhibit RECK expression in RBE cells. Survival analysis showed that patients with higher expression levels of microRNA-21 more often had a poor prognosis (P<0.05).
CONCLUSIONS: MicroRNA-21 may play an important role in cholangiocarcinoma invasion and metastasis, suggesting that MicroRNA-21 should be further evaluated as a biomarker for predicting cholangiocarcinoma prognosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23621247     DOI: 10.7314/apjcp.2013.14.2.829

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  26 in total

1.  MiR-592 inhibited cell proliferation of human colorectal cancer cells by suppressing of CCND3 expression.

Authors:  Zhehui Liu; Ruiqin Wu; Guanzeng Li; Peng Sun; Qinghua Xu; Zhimin Liu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 2.  MicroRNAs and benign biliary tract diseases.

Authors:  Sergio A Gradilone; Steven P O'Hara; Tetyana V Masyuk; Maria Jose Lorenzo Pisarello; Nicholas F LaRusso
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

Review 3.  The role of miRNAs in cholangiocarcinoma.

Authors:  Jessica A Howell; Shahid A Khan
Journal:  Hepat Oncol       Date:  2016-03-29

4.  LncRNA PCAT6 increased cholangiocarcinoma cell proliferation and invasion via modulating miR-330-5p.

Authors:  Yongjie Xin; Xu He; Wei Zhao; Meixiao Zhan; Yong Li; Jing Xiao; Ke He; Ligong Lu
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

5.  MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.

Authors:  Zhen Liu; Zhi-Yuan Jin; Chen-Hai Liu; Fang Xie; Xian-Sheng Lin; Qiang Huang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 6.  Emerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma.

Authors:  Hiroaki Haga; Irene Yan; Kenji Takahashi; Joseph Wood; Tushar Patel
Journal:  Gene Expr       Date:  2014

7.  MicroRNAs in Cholangiopathies.

Authors:  Steven P O'Hara; Sergio A Gradilone; Tetyana V Masyuk; James H Tabibian; Nicholas F LaRusso
Journal:  Curr Pathobiol Rep       Date:  2014-09-01

8.  A six-microRNA set as prognostic indicators for bile duct cancer.

Authors:  Ming Wang; Tian-Fu Wen; Lin-Hai He; Chuan Li; Wen-Jiang Zhu; Narasimha Murthy Trishul
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 9.  Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview.

Authors:  Simone Brivio; Massimiliano Cadamuro; Luca Fabris; Mario Strazzabosco
Journal:  Gene Expr       Date:  2017-10-25

10.  Identification of Cholangiocarcinoma Associated with Hepatolithiasis via the Combination of miRNA and Ultrasound.

Authors:  Wei Jiang; Xiaofei Deng; Ting Zhu; Yuya Wei; Zhen Lei; Meimei Guo; Jiong Yang
Journal:  Cancer Manag Res       Date:  2020-03-12       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.